These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30895693)

  • 1. Chromosome Transplantation: Correction of the Chronic Granulomatous Disease Defect in Mouse Induced Pluripotent Stem Cells.
    Castelli A; Susani L; Menale C; Muggeo S; Caldana E; Strina D; Cassani B; Recordati C; Scanziani E; Ficara F; Villa A; Vezzoni P; Paulis M
    Stem Cells; 2019 Jul; 37(7):876-887. PubMed ID: 30895693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Repair of CYBB in X-CGD iPSCs Requires Retention of Intronic Sequences for Expression and Functional Correction.
    Sweeney CL; Zou J; Choi U; Merling RK; Liu A; Bodansky A; Burkett S; Kim JW; De Ravin SS; Malech HL
    Mol Ther; 2017 Feb; 25(2):321-330. PubMed ID: 28153086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Mediated Knockout of Cybb in NSG Mice Establishes a Model of Chronic Granulomatous Disease for Human Stem-Cell Gene Therapy Transplants.
    Sweeney CL; Choi U; Liu C; Koontz S; Ha SK; Malech HL
    Hum Gene Ther; 2017 Jul; 28(7):565-575. PubMed ID: 28264583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TALEN-mediated functional correction of X-linked chronic granulomatous disease in patient-derived induced pluripotent stem cells.
    Dreyer AK; Hoffmann D; Lachmann N; Ackermann M; Steinemann D; Timm B; Siler U; Reichenbach J; Grez M; Moritz T; Schambach A; Cathomen T
    Biomaterials; 2015 Nov; 69():191-200. PubMed ID: 26295532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Repair of p47-CGD in iPSCs by CRISPR/Cas9: Functional Correction without Cleavage in the Highly Homologous Pseudogenes.
    Klatt D; Cheng E; Philipp F; Selich A; Dahlke J; Schmidt RE; Schott JW; Büning H; Hoffmann D; Thrasher AJ; Schambach A
    Stem Cell Reports; 2019 Oct; 13(4):590-598. PubMed ID: 31543470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease.
    De Ravin SS; Li L; Wu X; Choi U; Allen C; Koontz S; Lee J; Theobald-Whiting N; Chu J; Garofalo M; Sweeney C; Kardava L; Moir S; Viley A; Natarajan P; Su L; Kuhns D; Zarember KA; Peshwa MV; Malech HL
    Sci Transl Med; 2017 Jan; 9(372):. PubMed ID: 28077679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-mediated genotypic and phenotypic correction of a chronic granulomatous disease mutation in human iPS cells.
    Flynn R; Grundmann A; Renz P; Hänseler W; James WS; Cowley SA; Moore MD
    Exp Hematol; 2015 Oct; 43(10):838-848.e3. PubMed ID: 26101162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Mouse Model of X-Linked Chronic Granulomatous Disease for the Development of CRISPR/Cas9 Gene Therapy.
    Sevim-Wunderlich S; Dang T; Rossius J; Schnütgen F; Kühn R
    Genes (Basel); 2024 May; 15(6):. PubMed ID: 38927642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Restoration of gp91phox-Oxidase Activity by BAC Transgenesis and Gene Targeting in X-linked Chronic Granulomatous Disease iPSCs.
    Laugsch M; Rostovskaya M; Velychko S; Richter C; Zimmer A; Klink B; Schröck E; Haase M; Neumann K; Thieme S; Roesler J; Brenner S; Anastassiadis K
    Mol Ther; 2016 Apr; 24(4):812-22. PubMed ID: 26316390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells.
    Santilli G; Almarza E; Brendel C; Choi U; Beilin C; Blundell MP; Haria S; Parsley KL; Kinnon C; Malech HL; Bueren JA; Grez M; Thrasher AJ
    Mol Ther; 2011 Jan; 19(1):122-32. PubMed ID: 20978475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting.
    Zou J; Sweeney CL; Chou BK; Choi U; Pan J; Wang H; Dowey SN; Cheng L; Malech HL
    Blood; 2011 May; 117(21):5561-72. PubMed ID: 21411759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An AAVS1-targeted minigene platform for correction of iPSCs from all five types of chronic granulomatous disease.
    Merling RK; Sweeney CL; Chu J; Bodansky A; Choi U; Priel DL; Kuhns DB; Wang H; Vasilevsky S; De Ravin SS; Winkler T; Dunbar CE; Zou J; Zarember KA; Gallin JI; Holland SM; Malech HL
    Mol Ther; 2015 Jan; 23(1):147-57. PubMed ID: 25288370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
    Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
    Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous reactivation of the inactive X chromosome in mouse embryonal carcinoma cells.
    Yoshida I
    Cytogenet Genome Res; 2002; 99(1-4):44-51. PubMed ID: 12900544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced homology-directed repair for highly efficient gene editing in hematopoietic stem/progenitor cells.
    De Ravin SS; Brault J; Meis RJ; Liu S; Li L; Pavel-Dinu M; Lazzarotto CR; Liu T; Koontz SM; Choi U; Sweeney CL; Theobald N; Lee G; Clark AB; Burkett SS; Kleinstiver BP; Porteus MH; Tsai S; Kuhns DB; Dahl GA; Headey S; Wu X; Malech HL
    Blood; 2021 May; 137(19):2598-2608. PubMed ID: 33623984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Transgene Silencing of Myeloid-Specific Promoters in the
    Klatt D; Cheng E; Hoffmann D; Santilli G; Thrasher AJ; Brendel C; Schambach A
    Hum Gene Ther; 2020 Feb; 31(3-4):199-210. PubMed ID: 31773990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Clinical Efficacy and Safety Studies on G1XCGD, a Lentiviral Vector for Ex Vivo Gene Therapy of X-Linked Chronic Granulomatous Disease.
    Brendel C; Rothe M; Santilli G; Charrier S; Stein S; Kunkel H; Abriss D; Müller-Kuller U; Gaspar B; Modlich U; Galy A; Schambach A; Thrasher AJ; Grez M
    Hum Gene Ther Clin Dev; 2018 Jun; 29(2):69-79. PubMed ID: 29664709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome transplantation as a novel approach for correcting complex genomic disorders.
    Paulis M; Castelli A; Susani L; Lizier M; Lagutina I; Focarelli ML; Recordati C; Uva P; Faggioli F; Neri T; Scanziani E; Galli C; Lucchini F; Villa A; Vezzoni P
    Oncotarget; 2015 Nov; 6(34):35218-30. PubMed ID: 26485770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9-generated p47
    Wrona D; Siler U; Reichenbach J
    Sci Rep; 2017 Mar; 7():44187. PubMed ID: 28287132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentiviral gene therapy for X-linked chronic granulomatous disease recapitulates endogenous CYBB regulation and expression.
    Wong RL; Sackey S; Brown D; Senadheera S; Masiuk K; Quintos JP; Colindres N; Riggan L; Morgan RA; Malech HL; Hollis RP; Kohn DB
    Blood; 2023 Mar; 141(9):1007-1022. PubMed ID: 36332160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.